Friday, September 25, 2015

Partnership for integrated MES/DCS solutions.

ABB and Werum IT Solutions have signed a memorandum of understanding to collaborate on control system solutions for the global pharmaceutical and biotechnological industries. These solutions will enable customers to benefit from leading industry expertise for process control systems (DCS) and production management software.

ABB's Ilpo Ruohonen
Werum's Rüdiger Schlierenkämper
“Werum’s PAS-X MES solution combined with ABB's control systems will give our customers in the Life Science industry a seamless solution for their automation needs,” said Ilpo Ruohonen, Managing Director of ABB’s Control Technologies business unit. “This offering strengthens our portfolio for these rapidly growing industries.”

Werum IT Solutions is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biotechnological industries. Its out-of-the-box PAS-X software product is operating in approximately 800 installations of pharmaceutical and biotech companies around the world. Werum’s manufacturing IT solutions help pharma and biotech manufacturers to increase efficiency, improve productivity, and meet regulatory requirements.

The collaboration on joint solutions complements ABB’s control systems offering with the latest MES technology, which is seen as a key component for efficient production workflows in the life science industry. By bringing together both offerings, ABB and Werum will be able to deliver full-scope engineering and validation solutions according to the GAMP5 guideline and to comply with regulations such as FDA 21 CFR part 11.

“Our customers will benefit from integrated solutions paving the way towards the factory of the future,” said Rüdiger Schlierenkämper, CEO of Werum IT Solutions. “Werum, like ABB, is a sector leader. We look forward to working together with ABB on joint projects and to developing new ideas together. Driven by the innovative strength and global footprint of our two companies, we are well positioned to boost innovation for our customers around the globe.”

No comments:

Post a Comment